Navigation

Skiplink Navigation

Main Features

Roche first-quarter sales up

Roche expects "mid to high" single digit growth to continue in 2002

(Keystone)

Pharmaceutical group Roche has announced a six per cent rise in first-quarter sales to SFr7.37 billion.

The company expects mid to high single digit growth to continue for the remainder of the year.

Sales in Roche's drug division rose five percent, when expressed in Swiss francs, while its diagnostics businesses yielded 9 percent.

Franz Humer, Roche's CEO, rejected speculation that the company was preparing a merger with drug giant Novartis.

swissinfo with agencies

Neuer Inhalt

Horizontal Line


WEF 2018

WEF Teaser 2018

WEF 2019

subscription form

Form for signing up for free newsletter.

Sign up for our free newsletters and get the top stories delivered to your inbox.








Click here to see more newsletters